StockData
Belite Bio, Inc logo

Belite Bio, Inc (BLTE) stock

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30
$164.35−5.61 (-3.30%)

Close on Nov 13, 2026Market cap $6.47BP/E –Yield –

Belite Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Belite Bio's price to book ratio was 8.0× on Nov 11, 2026, against 30.0× a year earlier. Over the last 4 years it ranged from 7.4× to 36.9×, with a median of 14.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20268.0×−26.9
2025Dec 31, 202534.9×+14.6
2024Dec 31, 202420.3×−7.1
2023Dec 29, 202327.4×–

More Belite Bio figures

See a number that looks wrong?